Stock screenerAll disclosures →
EDGAR →
APRE
Conviction 32HealthcareScan · Thu, Jun 25, 2026APRE$0.7899-2.28%
ResistanceSupportVol 14Vol MA14 117.5K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price0.7899
Change-2.28%
Gap-2.28%
Rel volume0.03×
Avg volume120.65K
Avg $ vol93.22K
SMA 200.7752
SMA 500.8470
SMA 2000.9984
Price vs 50-6.74%
Price vs 200-20.88%
MA stackbearish
50/200 cross—
Supertrenddown · 0.9279
RSI (14)49
MACD hist0.01
MACD crossbull · 3d
Stoch %K / %D70 / 79
ADX (14)16
+DI / −DI17 / 17
RSI divergence—
MACD divergence—
ATR %+9.07%
ADR %8.64%
52w high2.08
52w low0.5900
From 52w high-62.02%
Above 52w low+33.88%
New 52w highNo
SqueezeOff
Bollinger width30.21%
%B0.56
Donchian pos46.63%
Donchian high0.9500
Donchian low0.6500
AVWAP (52w high)0.9309
vs AVWAP high-15.14%
AVWAP (52w low)0.9068
vs AVWAP low-12.89%
OBV trendFlat
Chaikin MF (20)-0.17
Today vs 20d0.03×
Avg vol (14d)117.5K
Avg vol (20d)120.65K
Avg $ vol (20d)93.22K
Market cap9.78M
RS 3m (vs SPY)+7.74%
RS 6m (vs SPY)-20.82%
RS line new highNo
Trend template2/8
Technical rank20.6
1 week+1.30%
1 month-13.20%
3 months+17.72%
6 months-15.18%
1 year-51.69%
YTD-7.40%
P/E-0.78
P/B0.24
P/S—
P/FCF-0.76
EPS-1.93
Div yield—
ROE-30.30%
ROA-26.46%
Debt/Eq—
Current8.92
EV/EBITDA2.78
Gross margin—
Net margin—
Rev growth—
EPS growth2.77%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-36.69M
Revenue—
Net income-3.29M
Gross profit—
Free cash flow-12.91M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out12.38M
Employees8
ListedThu, Oct 3, 2019
Free float7.76M
Float %67.8%
Short interest119.01K
Days to cover0.8d
Short volume43.5%
Squeeze score9 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction32 / 100
Pattern quality—
Tech rank20.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.02
Support0.6801
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in APRE
No recent disclosed trades by Congress in APRE. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in APRE · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Seizinger Bernd R. Director · Common Stock · 2026-06-16 | Grant | 3.13K | — | 2026-06-16 | 2026-06-17 |
Seizinger Bernd R. Director · Stock Options (Right to Buy) · 2026-06-16 | Grant | 12.55K | — | 2026-06-16 | 2026-06-17 |
Pamukcu Rifat Director · Common Stock · 2026-06-16 | Grant | 3.13K | — | 2026-06-16 | 2026-06-17 |
Pamukcu Rifat Director · Stock Options (Right to Buy) · 2026-06-16 | Grant | 12.55K | — | 2026-06-16 | 2026-06-17 |
Duey Marc Director · Common Stock · 2026-06-16 | Grant | 3.13K | — | 2026-06-16 | 2026-06-17 |
Duey Marc Director · Stock Options (Right to Buy) · 2026-06-16 | Grant | 12.55K | — | 2026-06-16 | 2026-06-17 |
BIZZARI JEAN-PIERRE Director · Common Stock · 2026-06-16 | Grant | 3.13K | — | 2026-06-16 | 2026-06-17 |
BIZZARI JEAN-PIERRE Director · Stock Options (Right to Buy) · 2026-06-16 | Grant | 12.55K | — | 2026-06-16 | 2026-06-17 |
HENNEMAN JOHN B III Director · Common Stock · 2026-06-16 | Grant | 3.13K | — | 2026-06-16 | 2026-06-17 |
HENNEMAN JOHN B III Director · Stock Options (Right to Buy) · 2026-06-16 | Grant | 12.55K | — | 2026-06-16 | 2026-06-17 |
SEC filings
EDGAR filings in APRE · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.